PG-033 placebo comparator
Sponsors
Prime Gene Therapeutics Co., Ltd.
Conditions
Lichen Simplex Chronicus
Phase 1
A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults
RecruitingNCT07013097
Start: 2025-05-23End: 2026-12-31Target: 52Updated: 2026-06-02
A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants.
Not yet recruitingNCT07619183
Start: 2026-06-04End: 2026-12-30Target: 30Updated: 2026-06-01